On Tuesday, October 1, PolarisQB hosted a webinar titled “Find Your Star: Using QuADD to Accelerate Drug Discovery for Versatile Targets” that demonstrated how our Quantum-Aided Drug Design platform can research versatile types of drug targets, including protein-protein interactions. This platform allows researchers to search a chemical space of over 1030 potential molecules for candidates that satisfy a number of desired drug-like characteristics identified by molecular research teams.
The webinar featured our Director of Computational Chemistry, Dr. Ken Byler, and one of our Computational Chemists, Dr. Anna Petroff describing the ways that QuADD can be used to accomplish goals surrounding IP protection, acceleration of molecular research for novel drug discovery, as well as utilization of QuADD with available commercial libraries.
